CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pancaro, C.
Right arrow Articles by Peduto, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pancaro, C.
Right arrow Articles by Peduto, V. A.
Canadian Journal of Anesthesia 52:591-594 (2005)
© Canadian Anesthesiologists' Society, 2005

General Anesthesia

Apnea during induction of anesthesia with sevoflurane is related to its mode of administration

[L’apnée pendant l’induction de l’anesthésie avec du sévoflurane est reliée au mode d’administration]

Carlo Pancaro, MD*, Simone Giovannoni, MD{dagger}, Adelchi Toscano, MD{dagger} and Vito Aldo Peduto, MD{dagger}

* From the Department of Anesthesiology and Perioperative Medicine, Brigham & Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and
{dagger} the Department of Anesthesiology and Intensive Care, University of Perugia, Perugia Italy.

Address correspondence to: Dr. Carlo Pancaro, Department of Anesthesiology and Perioperative Medicine, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, 02115 Boston, MA, USA. E-mail: carlopancaro{at}hotmail.com

Purpose: The incidence and duration of apnea during sevoflurane anesthesia have not been fully characterized. We hypothesized that sevoflurane at slowly increasing concentrations reduces incidence and shortens the duration of apnea compared to administration of a highly concentrated anesthetic mixture.

Methods: 131 women were randomly assigned to receive 35% oxygen in air and sevoflurane at: incremental concentrations of 1%, from 1% to 8% (group 1–8%, n = 42); decremental-incremental concentrations of 2%, from 8% to 4% and then from 4% to 8% (group 8–4–8%, n = 36); or fixed concentrations of 8% for induction of anesthesia (group 8%, n = 53). A blinded investigator observed whether and for how long patients stopped breathing.

Results: All groups reached 2.5 minimum alveolar concentration of end-tidal sevoflurane. Although apnea was observed in all groups, it was more frequent in the 8% group than in 1 to 8% (68% vs 21%, P < 0.05) or 8 to 4 to 8% groups (68% vs 20%, P < 0.05). Duration of apnea was also more pronounced in the 8% group than in 1 to 8% and 8 to 4 to 8% groups ( 58 ± 25 s vs 32 ± 18 sec, P < 0.05 and vs 35 ± 16 sec, P < 0.05, respectively).

Conclusions: Sevoflurane induces apnea more frequently and for longer duration at a fixed high concentration compared to incremental or decremental-incremental concentrations. Decremental-incremental concentrations offer the additional advantage of a speed of induction similar to that elicited by the 8% concentration.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Canadian Anesthesiologists' Society.